Antigenics looks to foreign regulators before U.S.
July 01, 2009 at 18:57 PM EDT
Scrappy biotech firm's stock has soared on hopes that it will finally be able to win regulatory approval for a kidney-cancer vaccine.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|